Subject
Clinical Neurology,Neurology,General Medicine
Reference39 articles.
1. Classifying PML risk with disease modifying therapies;Berger;Mult. Scler. Relat. Disord.,2017
2. JC virus antibody status underestimates infection rates;Berger;Ann. Neurol,2013
3. Biogen. TYSABRI® (natalizumab): PML incidence in patients receiving TYSABRI. 2016. https://medinfo.biogen.com/.
4. Progressive multifocal leukoencephalopathy;Brooks;Neurol. Clin.,1984
5. Atlas of multiple sclerosis 2013: a growing global problem with widespread inequity;Browne;Neurol.,2014
Cited by
16 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献